In the first half of 2026, a clear pattern showed up across large life sciences organizations. One after another, they signed deals to bring an external AI capability inside: a discovery model from a specialized biotech, a single-cell analysis platform, an agentic assistant running on a hyperscaler's cloud. The models are impressive. The demos land. The board is happy.
Then the real work starts, and it has almost nothing to do with the model.
The hard part is wiring someone else's AI into a regulated internal data environment without losing track of where the data came from, what the model did with it, and who can answer for the output when a regulator or an auditor asks. The bottleneck in life sciences has moved. It is no longer about proving that AI works. It is about governing and scaling it on data you can trust and trace.
The bottleneck moved from the model to the data layer
For most of the last two years, the question was whether the model was good enough. That question is largely settled. The models are good enough. What most teams underestimate is the layer underneath them.
Gartner projects that through 2026, organizations will abandon roughly 60 percent of AI projects that are not supported by AI-ready data. In the same research, only 37 percent of organizations said they were confident in their data management practices for AI, based on a 2024 survey of 248 data leaders. That gap is the story. The failures rarely trace back to a weak algorithm. They trace back to data that is fragmented, inconsistent, or impossible to trace end to end.
An external model makes this sharper, not softer. When you connect an outside AI platform to your internal data, you inherit two things at once: a capability you did not build, and a new set of questions about lineage, access, and accountability that your existing controls were never designed to answer.
Why external AI raises the governance stakes
The uncomfortable truth is that adoption is running ahead of control. In an EY poll of 500 technology leaders published in early 2026, 78 percent said AI adoption is outpacing their organization's ability to manage it, and 52 percent of department-level AI initiatives were operating without formal approval or oversight. In the same survey, 45 percent reported a confirmed or suspected leak of sensitive data through unauthorized third-party AI tools.
In a regulated environment, that is not a productivity footnote. It is a data integrity and accountability problem. If an external model touches clinical, safety, or market access data, the organization still owns the answer to three questions: where did this data come from, what transformed it, and who approved the model that produced this output. McKinsey's most recent state-of-AI work found that organizations now actively manage around four AI-related risks on average, up from two in 2022, yet only 28 percent said their CEO owns AI governance and 17 percent said their board does. The oversight is thin at exactly the level where external AI decisions get made.
What keeping control actually requires
Teams that bring external AI inside without losing control tend to treat governance as an engineering surface, not a policy document. In practice that means a small number of concrete capabilities.
Source data immutability and lineage, so any output can be traced back to the exact inputs and transformations that produced it. Access control that follows the data into the model and back out again, rather than stopping at the database. Audit logging that records every read, write, and model call, not just the final result. And a record of which model version, with which parameters, produced which output, so a result can be reconstructed months later.
None of this is exotic. Modern governance tooling already captures column-level lineage automatically and extends the same access and audit model from data assets to AI assets. The reason it still breaks is that most environments bolt the external model onto the side of a data estate that was never traceable in the first place. The tooling can only govern what the underlying architecture exposes.
Where the work tends to land
Almost every time, the work lands in the data layer, not the model layer and not the dashboard. This is the part that is easy to underestimate when the external platform looks ready to go.
A useful way to see it: a domain-specific AI agent is only as trustworthy as the fields it can reach. Recent engineering work on a life sciences AI query agent expanded structured data coverage roughly tenfold and cut query time by about 35 percent, but the result came from curating more than 250 fields into a governed, queryable layer first. The agent was the last mile. The foundation was the project. The same pattern shows up in consolidation work, where a post-merger migration of 2.5TB of regulated healthcare data with near-zero user-facing downtime mattered less for the migration itself than for the traceable, governed environment it left behind.
The lesson repeats across CROs, pharma, biotech, and digital health. External AI does not fix a disconnected data estate. It exposes it faster.
Most life sciences teams do not want to buy a governance platform. They want to put an external model to work without a risk event, and without waiting on a multi-year rebuild. The way to start is usually not a platform program. It is a focused four to six week engagement that maps the data an external model will actually touch, closes the lineage and access gaps that would block it, and puts a governed, traceable path in place before the model goes near production data. That is the sequence we keep seeing separate the pilots that graduate from the ones that quietly stall.
Final Thought
A lot of what looks like an AI decision in 2026 is really a data governance decision wearing a model's face.
The organizations bringing external AI inside successfully are not the ones with the best models. They are the ones who can still answer, at any moment, where the data came from and what the model did with it. That ability lives in the data layer, and it is built before the model arrives, not after.